Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Many women with hard-to-treat acne also have PCOS.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Non-obese women with hair loss have higher heart disease risk.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.